| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | CA2378606A1 Agent for occluding blood vessels |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377734A1 Heparin compositions that inhibit clot associated coagulation factors |
| 01/11/2001 | CA2376944A1 A substantially crystalline form of melagatran |
| 01/11/2001 | CA2375751A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2373753A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | CA2373735A1 Fviia antagonists |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1066835A1 Composition containing the pepino extracts for lowering the concentration of alcohol in the blood and method for producing the same |
| 01/10/2001 | EP1066834A2 Pharmaceutical compositions comprising a phagocyte-modulating agent |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066323A1 Treatment and prevention of vascular disease |
| 01/10/2001 | EP1066265A1 Pyridazinone hydrochloride compound and method for producing the same |
| 01/10/2001 | EP1066057A1 Hemoglobin-polysaccharide conjugates |
| 01/10/2001 | EP1066056A1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 01/10/2001 | CN1279606A Use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 01/10/2001 | CN1279582A Serotonin containing formulation or oral administration and method of use |
| 01/10/2001 | CN1279236A Salt as thrombin inhibitor |
| 01/10/2001 | CN1060346C Chinese drug 'Linshuiling Capsule' for curing hydrops and preparing process |
| 01/10/2001 | CN1060337C Bear bile powder enteric capsule and preparing technology |
| 01/09/2001 | US6172116 Use of aminoadamantane compounds as immunoregulators |
| 01/09/2001 | US6172100 Administering aminated 1-benzyl-2-phenylindole derivatives; benzylation |
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6171578 Glycoprotein iib/iiia receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. |
| 01/04/2001 | WO2001000859A1 Method of inducing angiogenesis by micro-organs |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000618A1 Benzamide derivatives |
| 01/04/2001 | WO2001000603A1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/04/2001 | WO2001000601A1 Novel 4-(2-oxodihydrooxadiazinylphenyl)amides and the use thereof for treating anemia |
| 01/04/2001 | WO2001000598A1 N-[4-(6-oxotetrahydrotriazinyl)phenyl]amides and use thereof |
| 01/04/2001 | WO2001000590A1 Substituted 6-[4-(oxymethyl)-phenyl]-dihydropyridazinones and use thereof |
| 01/04/2001 | WO2001000589A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
| 01/04/2001 | WO2001000585A1 Pyrazolidinol compounds |
| 01/04/2001 | WO2001000576A1 Indole and indazole urea-peptoids as thrombin receptor antagonists |
| 01/04/2001 | WO2001000188A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 01/04/2001 | WO2001000047A1 Prophylactic dietary supplement based on milk |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000052145A3 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 01/04/2001 | DE19929787A1 Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung New 4- (2-Oxodihydrooxadiazinylphenyl) amides and their use |
| 01/04/2001 | DE19929785A1 Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung Tetrahydroquinolinyl-6-methyldihydrothiadiazinon derivatives and their use |
| 01/04/2001 | DE19929783A1 Substituierte 6-[4-(Oxymethyl)-phenyl]-dihydropyridazinone und ihre Verwendung Substituted 6- [4- (oxymethyl) phenyl] -dihydropyridazinone and their use |
| 01/04/2001 | DE19929782A1 6-Carboxyphenyldihydropyridazinon-Derivate und ihre Verwendung 6-Carboxyphenyldihydropyridazinon derivatives and their use |
| 01/04/2001 | DE19929781A1 N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung N- [4- (6-Oxotetrahydrotriazinyl) phenyl] amides and their use |
| 01/04/2001 | CA2435411A1 Method of inducing angiogenesis by micro-organs |
| 01/04/2001 | CA2377541A1 Method of inducing angiogenesis by micro-organs |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2377224A1 Inhibitors of the integrin .alpha.v.beta.6 |
| 01/04/2001 | CA2377200A1 Pyrazolidinol compounds |
| 01/04/2001 | CA2377117A1 6-carboxyphenyldihydropyridazinone derivatives and use thereof |
| 01/04/2001 | CA2376891A1 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064270A2 Disubstituted pyrazolines and triazolines as factor xa inhibitors |
| 01/03/2001 | EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 01/03/2001 | EP1064021A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/03/2001 | EP1064010A1 Peptide compositions and formulations and use of same |
| 01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
| 01/03/2001 | EP0828759B1 Process of high purity albumin production |
| 01/03/2001 | CN1278866A MPL ligand analogs |
| 01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1278530A Novel peptide derivative |
| 01/03/2001 | CN1278433A Thrombolytic medicine and its preparation and use |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/02/2001 | US6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | CA2068064C Fibrinogen receptor antagonists |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/02/2001 | CA2027593C Composition with antiaggreting action on platelet, for therapeutic uses |
| 01/02/2001 | CA2025070C Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof |
| 01/02/2001 | CA1341160C Bovine granulocyte-macrophage colony stimulating factor |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078930A1 Method for enhancing hematopoiesis |
| 12/28/2000 | WO2000078811A1 Human antithrombin variants |
| 12/28/2000 | WO2000078792A1 Method for purification of proteins |
| 12/28/2000 | WO2000078779A2 N-pyrazole a2a receptor agonists |
| 12/28/2000 | WO2000078778A2 C-pyrazole a2a receptor agonists |
| 12/28/2000 | WO2000078777A1 Propargyl phenyl ether a2a receptor agonists |
| 12/28/2000 | WO2000078776A2 Thiophene a2a receptor agonists |
| 12/28/2000 | WO2000078762A1 Indoloazepines as vasopressin receptor antagonists |
| 12/28/2000 | WO2000078749A1 Sulfonamide derivative as factor xa inhibitor |
| 12/28/2000 | WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 12/28/2000 | WO2000078364A2 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 12/28/2000 | WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses |
| 12/28/2000 | WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |